Breast Cancer Business, International Growth Drive up Genomic Health's Q2 Revenues 17 Percent
August 04, 2011
Breast Cancer Business, International Growth Drive up Genomic Health's Q2 Revenues 17 Percent
Net income in the second quarter rose 166 percent to $2.3 million, or $.08 per share, from $865,000, or $.03 a share, a year ago, edging out analysts' EPS expectations of $.02.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.